Purdue Pharma L.P. et al v. Accord Healthcare Inc.
Case Number:
1:20-cv-01362
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
Companies
Sectors & Industries:
-
April 11, 2023
Purdue Loses Case To Stop Generic OxyContin
The bankrupt Purdue Pharma lost its legal effort to use patent laws to block an Indian drugmaker from launching a generic version of OxyContin when a federal judge in Delaware decided on Tuesday that some of the patents covering the drug's newer "abuse-deterrent" features could be found in decade-old academic articles and patent paperwork.
-
September 15, 2022
IP Forecast: PTAB To Eye Patent Tied To Intel's $2.2B Loss
The Patent Trial and Appeal Board next week will dive into a controversial legal effort to wipe out claims in a microchip patent tied to part of a $2.18 billion jury verdict against Intel that's being closely watched by the tech industry, lawmakers and the patent office's director. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.